| General Information of Drug Metabolite (DM) (ID: DM006575) |
| DM Name |
3beta-OH-desogestrel
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2C9 (CYP2C9)
|
DME0019
|
| Oxidation - Hydrolyzationn |
Desogestrel
|
[1] |
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME0021
|
| Oxidation - Hydrolyzationn |
Desogestrel
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
hydroxysteroid dehydrogenase (HSD)
|
DMEN350
|
| Oxidation - Oxidationn |
Desogestrel
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Desogestrel |
DR0438
|
Phase 4 |
Female pelvic pain |
|
|
| References |
| 1 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
